Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 433 to 436 of 436 entries
Sorted by: Best Match Show Resources per page
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Frontiers in microbiology

Hartley MG, Norville IH, Richards MI, Barnes KB, Bewley KR, Vipond J, Rayner E, Vente A, Armstrong SJ, Harding SV.
PMID: 34917048
Front Microbiol. 2021 Nov 30;12:760698. doi: 10.3389/fmicb.2021.760698. eCollection 2021.

Finafloxacin is a novel fluoroquinolone with optimal antibacterial activity in low pH environments, therefore offering a therapeutic advantage over some traditional antibiotics, in treating bacterial infections associated with acidic foci.

Cite
Hartley MG, Norville IH, Richards MI, et al. Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Front Microbiol. 2021;12:760698doi: 10.3389/fmicb.2021.760698.
Hartley, M. G., Norville, I. H., Richards, M. I., Barnes, K. B., Bewley, K. R., Vipond, J., Rayner, E., Vente, A., Armstrong, S. J., & Harding, S. V. (2021). Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Frontiers in microbiology, 12760698. https://doi.org/10.3389/fmicb.2021.760698
Hartley, M Gill, et al. "Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever." Frontiers in microbiology vol. 12 (2021): 760698. doi: https://doi.org/10.3389/fmicb.2021.760698
Hartley MG, Norville IH, Richards MI, Barnes KB, Bewley KR, Vipond J, Rayner E, Vente A, Armstrong SJ, Harding SV. Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Front Microbiol. 2021 Nov 30;12:760698. doi: 10.3389/fmicb.2021.760698. eCollection 2021. PMID: 34917048; PMCID: PMC8670379.
Copy Download .nbib Format: NLM
Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants.

The Journal of pediatrics

Glasgow MJ, Edlin R, Harding JE.
PMID: 32634402
J Pediatr. 2020 Nov;226:80-86.e1. doi: 10.1016/j.jpeds.2020.06.073. Epub 2020 Jul 04.

OBJECTIVE: To evaluate the long-term costs and impact on quality of life of using prophylactic dextrose gel in patients at increased risk of developing neonatal hypoglycemia.STUDY DESIGN: A cost-utility analysis was performed from the perspective of the health system,...

Cite
Glasgow MJ, Edlin R, Harding JE. Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants. J Pediatr. 2020;226:80-86.e1doi: 10.1016/j.jpeds.2020.06.073.
Glasgow, M. J., Edlin, R., & Harding, J. E. (2020). Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants. The Journal of pediatrics, 22680-86.e1. https://doi.org/10.1016/j.jpeds.2020.06.073
Glasgow, Matthew J, et al. "Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants." The Journal of pediatrics vol. 226 (2020): 80-86.e1. doi: https://doi.org/10.1016/j.jpeds.2020.06.073
Glasgow MJ, Edlin R, Harding JE. Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants. J Pediatr. 2020 Nov;226:80-86.e1. doi: 10.1016/j.jpeds.2020.06.073. Epub 2020 Jul 04. PMID: 32634402; PMCID: PMC7779688.
Copy Download .nbib Format: NLM
Terpene polyacrylate TPA5 shows favorable molecular hydrodynamic properties as a potential bioinspired archaeological wood consolidant.

Scientific reports

Cutajar M, Andriulo F, Thomsett MR, Moore JC, Couturaud B, Howdle SM, Stockman RA, Harding SE.
PMID: 33795726
Sci Rep. 2021 Apr 01;11(1):7343. doi: 10.1038/s41598-021-86543-1.

There is currently a pressing need for the development of novel bioinspired consolidants for waterlogged, archaeological wood. Bioinspired materials possess many advantages, such as biocompatibility and sustainability, which makes them ideal to use in this capacity. Based on this,...

Cite
Cutajar M, Andriulo F, Thomsett MR, et al. Terpene polyacrylate TPA5 shows favorable molecular hydrodynamic properties as a potential bioinspired archaeological wood consolidant. Sci Rep. 2021;11(1):7343doi: 10.1038/s41598-021-86543-1.
Cutajar, M., Andriulo, F., Thomsett, M. R., Moore, J. C., Couturaud, B., Howdle, S. M., Stockman, R. A., & Harding, S. E. (2021). Terpene polyacrylate TPA5 shows favorable molecular hydrodynamic properties as a potential bioinspired archaeological wood consolidant. Scientific reports, 11(1), 7343. https://doi.org/10.1038/s41598-021-86543-1
Cutajar, Michelle, et al. "Terpene polyacrylate TPA5 shows favorable molecular hydrodynamic properties as a potential bioinspired archaeological wood consolidant." Scientific reports vol. 11,1 (2021): 7343. doi: https://doi.org/10.1038/s41598-021-86543-1
Cutajar M, Andriulo F, Thomsett MR, Moore JC, Couturaud B, Howdle SM, Stockman RA, Harding SE. Terpene polyacrylate TPA5 shows favorable molecular hydrodynamic properties as a potential bioinspired archaeological wood consolidant. Sci Rep. 2021 Apr 01;11(1):7343. doi: 10.1038/s41598-021-86543-1. PMID: 33795726; PMCID: PMC8016987.
Copy Download .nbib Format: NLM
A systematic review of early speech interventions for children with cleft palate.

International journal of language & communication disorders

Lane H, Harding S, Wren Y.
PMID: 34767284
Int J Lang Commun Disord. 2022 Jan;57(1):226-245. doi: 10.1111/1460-6984.12683. Epub 2021 Nov 12.

BACKGROUND: Children with cleft palate with or without cleft lip (CP±L) are at high risk of problems with early speech sound production, and these difficulties can persist into later childhood. Early intervention could help to reduce the number of...

Cite
Lane H, Harding S, Wren Y. A systematic review of early speech interventions for children with cleft palate. Int J Lang Commun Disord. 2021;57(1):226-245doi: 10.1111/1460-6984.12683.
Lane, H., Harding, S., & Wren, Y. (2022). A systematic review of early speech interventions for children with cleft palate. International journal of language & communication disorders, 57(1), 226-245. https://doi.org/10.1111/1460-6984.12683
Lane, Hannah, et al. "A systematic review of early speech interventions for children with cleft palate." International journal of language & communication disorders vol. 57,1 (2022): 226-245. doi: https://doi.org/10.1111/1460-6984.12683
Lane H, Harding S, Wren Y. A systematic review of early speech interventions for children with cleft palate. Int J Lang Commun Disord. 2022 Jan;57(1):226-245. doi: 10.1111/1460-6984.12683. Epub 2021 Nov 12. PMID: 34767284.
Copy Download .nbib Format: NLM
Showing 433 to 436 of 436 entries